Importantly, in line with the differentiation role of PRL in the breast, PRL mRNA levels were found to be associated with more differentiated tumors, early stage, smaller tumor size, absence of distant metastasis and prolonged relapse-free survival (RFS) [45–47]. The gene discussed is PRL; the disease is neoplasm.